Blavatnik Awards for Young Scientists
Internal Application Deadline: October 11, 2018
The Blavatnik National Awards for Young Scientists recognize the country's most promising faculty-rank researchers in Life Sciences, Physical Sciences & Engineering, and Chemistry. One Blavatnik Laureate in each disciplinary category will receive $250,000 in unrestricted funds.
Eligibility & Requirements
*Age limit exceptions will be considered by the
Academy in exceptional circumstances upon a detailed written submission
from the nominating institution received by the Academy at firstname.lastname@example.org
no later than Wednesday, October 31, 2018.
Internal Nomination Process:
Interested applicants should submit the following documents to FoundationRelations@jhu.edu:
Request for Proposals for Collaborative Research Projects - Diana Helis Henry Medical Research Foundation and Adrienne Helis Malvin Medical Research Foundation
Application deadline: October 29, 2018
The Johns Hopkins University School of Medicine
Institute for Cell Engineering is soliciting proposals to conduct collaborative,
Parkinson's Disease-related research with the Diana Helis Henry Medical
Research Foundation and Adrienne Helis Malvin Medical Research Foundation.
The primary goal of this collaborative research opportunity is to foster
fundamental, discovery-driven biomedical research that may lead to target
validation, new target identification and/or drug development. Whereas
projects may contain a drug development aim, they should not focus solely
on drug development. The Helis medical research foundations encourage
risk taking and value the premise, hypothesis/idea of the project over
the extent of preliminary data.
Submitted projects will be subject to an internal
review. Those ranked most highly in this round of review will also receive
external review by the Helis Medical Research Research Advisory Council.
Projects will be considered for two to three years of collaboration
and may request up to $300,000 total cost per year. The total cost is
inclusive of rent paid to JHU for identified laboratory space and 15
percent indirect costs.
Investigators who are interested in applying for
Helis medical research foundation collaboration may contact Dr. Ted
Dawson (email@example.com) to address
any scientific questions. Since there are unique administrative aspects
to this sponsored research mechanism, please contact Nikia Whorley (firstname.lastname@example.org)
for administrative and/or budgetary guidance.
Projects must be submitted using the application
form, which is available here: https://jh.box.com/s/95bkirkc5nkv0fh8rqg1xzx8kh30gln1.
A sample budget is also available.
The deadline for final project submission is Monday,
October 29, 2018. Please email applications to Dr. Jennifer Roshek
oral presentations by the PIs of the projects selected as finalists
to representatives from the Helis medical research foundation (date
to be determined), those chosen for collaboration will begin on or around
May 1, 2019.
Please note: Principal investigators
of funded projects, or their designee if the principal investigator
is out of town, are required to attend and provide updates at the monthly
Helis project seminar series. In addition, it is expected that the principal
investigator will attend Helis sponsored activities.
No application deadline
The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.
The ability to image alpha-synuclein deposition
in the brain would be a game-changing achievement for the Parkinson's
disease (PD) field. The accumulation of aggregated alpha-synuclein is
a pathological hallmark of PD and a priority target for drug development
given its hypothesized contribution to neurodegeneration. In vivo imaging
of alpha-synuclein pathology could be useful as a biomarker of the presence
of disease and disease progression and as a pharmacodynamic tool for
drug development. With this prize, the Foundation seeks to attract research
teams and accelerate momentum to speed the development of such a tracer.
Contestants: Anyone is eligible for
the prize who agrees to all contest rules. Contestants may be MJFF funded
or not and can be from either academia or industry.
Criteria for winning: The winning contestant
must demonstrate that the radiotracer binds with relatively high selectivity
to alpha-synuclein according to pre-specified criteria and must demonstrate
proof-of-concept in human subjects, including people with Parkinson's
disease and/or another synucleinopathy. See below for more details on
Timeline: There is no deadline
for submissions. The $2 million award will be issued to the first
contestant who submits compelling evidence of a viable selective tracer
and agrees to its widespread use. If no award is given by mid-2018,
The Michael J. Fox Foundation will evaluate the state of the field and
utility of such a prize.